Anti-angiogenesis in Lung Cancer: Current Situation, Progress and Confusion

Lung cancer is a highly vascular tumors, over the past ten years, anti-angiogenes is has been proved to be an effective and highly promising combinational treatment. The data of the combination of anti-angiogenesis with chemotherapy, targeted therapy, immunotherapy has been constantly updating. Advanced lung cancer patients, no matter different groups or different stages of the disease, are benefited from anti-angiogenes. In this paper, based on the clinical status and unsolved problems, combined with the latest clinical and translational research data, we reviewed the current anti-angiogenesis treatment of lung cancer. 
 DOI: 10.3779/j.issn.1009-3419.2022.101.16
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research